Internal Medicine, Pulmonary Disease · Anderson, IN
NPI
1740215805
Since 2006
Specialty
Internal Medicine, Pulmonary Disease
Code 207RP1001X
Group practices
2
Medicare group memberships
Hospitals
4
Hospital affiliations
2101 Jackson St, #110
Anderson, IN, 46016
Phone (765) 643-6012
Groups this clinician bills Medicare through
Medicare paid, 2024
$110K
1,380 services
Medicare patients, 2024
432
Average age 72
Drug cost, 2024
$2.4M
4,866 prescriptions
Company payments, 2025
$2,322
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Pablo Molina was code 99233 (hospital e&m - subsequent), 396 times for 108 patients. In total Pablo Molina billed 1,380 services in 27 codes, and Medicare paid $110K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 396 | 108 | $85.83 | $34K |
| 99214 Office E&M - Established | Office | 200 | 122 | $80.84 | $16K |
| 99232 Hospital E&M - Subsequent | Facility | 146 | 69 | $56.76 | $8,287 |
| 99213 Office E&M - Established | Office | 146 | 118 | $59.08 | $8,625 |
| 99223 Hospital E&M - Initial | Facility | 87 | 73 | $125.31 | $11K |
| 99291 Critical Care E&M | Facility | 79 | 17 | $150.15 | $12K |
| 99238 Hospital Discharge Management | Facility | 50 | 40 | $58.34 | $2,917 |
| 32557 Other Organ Systems | Facility | 47 | 16 | $101.06 | $4,750 |
| G0399 Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Facility | 41 | 41 | $26.30 | $1,078 |
| 95811 Sleep Study | Facility | 34 | 34 | $82.05 | $2,790 |
| 95810 Sleep Study | Facility | 31 | 31 | $77.95 | $2,416 |
| 99204 Office E&M - New | Office | 22 | 22 | $107.45 | $2,364 |
By year: 2022 $152K for 1,807 services; 2023 $126K for 1,491 services; 2024 $110K for 1,380 services.
Medicare prescription drug claims, 2024
In 2024, the drug Pablo Molina prescribed most often to Medicare patients was Montelukast Sodium, with 931 prescriptions and refills. In total Pablo Molina wrote 4,866 Medicare prescriptions that cost $2.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 931 | 2,221 | 250 | $9,045 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 463 | 648 | 127 | $14K |
| Prednisone Generic | 350 | 456 | 135 | $1,186 |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 242 | 382 | 54 | $244K |
| Cefuroxime Cefuroxime Axetil | 179 | 179 | 116 | $3,950 |
| Breo Ellipta Fluticasone/Vilanterol | 175 | 255 | 38 | $101K |
| Budesonide-Formoterol Fumarate Budesonide/Formoterol Fumarate | 156 | 246 | 37 | $44K |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 117 | 235 | 32 | $25K |
| Symbicort Budesonide/Formoterol Fumarate | 110 | 176 | 33 | $41K |
| Xolair Omalizumab | 105 | 110 | 11 | $426K |
| Doxycycline Hyclate Generic | 87 | 87 | 57 | $617 |
| Zolpidem Tartrate Generic | 81 | 169 | 23 | $761 |
| Ventolin Hfa Albuterol Sulfate | 80 | 85 | 20 | $5,353 |
| Clonazepam Generic | 63 | 99 | Under 11 | $237 |
| Combivent Respimat Ipratropium/Albuterol Sulfate | 59 | 67 | Under 11 | $32K |
Brand drugs: - claims; generic drugs: 3,048 claims; opioid claims: 35.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Pablo Molina $2,322 ($2,322 in general payments such as food, travel and fees) from 23 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $454.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 18 | $454 |
| GlaxoSmithKline, LLC. GSK | 24 | $437 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 6 | $152 |
| Insmed, Inc. INSM | 9 | $151 |
| Regeneron Healthcare Solutions, Inc. REGN | 7 | $138 |
| Genzyme Corporation SNY | 5 | $108 |
| Actelion Pharmaceuticals US, Inc. JNJ | 5 | $98.22 |
| Grifols USA, LLC | 4 | $95.38 |
| Amgen Inc. AMGN | 4 | $89.55 |
| Verona Pharma, Inc. VRNA | 3 | $74.61 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.